Bausch Health Corp - רווח נקי למניה (EPS TTM) BHC

Bausch Health Companies (BHC) relies on inelastic demand in gastroenterology and ophthalmology, maintaining moderate pricing power. Production is automated via sterile lines, although formula development requires scientist involvement. Mature assets serve as cash generators despite high debt levels. The current metric level is -2.30, and the GURU.Markets interface illustrates this annual net income per share trend.

Trailing twelve-month earnings per share (EPS TTM) measures the portion of profit allocated to each ordinary share, allowing for an assessment of real capital generation efficiency regardless of the total volume of issuance. Analyzing the current rolling annual EPS helps identify margin erosion at Bausch Health Companies (BHC) driven by debt load and the expansion of cheap generics, signaling a loss of the company's competitive advantages.